Global Enterobacteriaceae Infection Drug Market Growth (Status and Outlook) 2025-2031

September 2025 | 85 pages | ID: G0DE40AFCC3EN
LP Information

Abstracts

According to this study, the global Enterobacteriaceae Infection Drug market size will reach US$ million by 2031.

Enterobacteriaceae infections are caused by Enterobacter species, pathogens responsible for causing severe infections including bacteremia, urinary tract infections, lower respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Enterobacteriaceae Infection Drug Industry Forecast” looks at past sales and reviews total world Enterobacteriaceae Infection Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Enterobacteriaceae Infection Drug sales for 2025 through 2031. With Enterobacteriaceae Infection Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enterobacteriaceae Infection Drug industry.

This Insight Report provides a comprehensive analysis of the global Enterobacteriaceae Infection Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Enterobacteriaceae Infection Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Enterobacteriaceae Infection Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enterobacteriaceae Infection Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enterobacteriaceae Infection Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Enterobacteriaceae Infection Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Beta-lactams Drugs
• Carbapenems Drugs
• Fluoroquinolones Drugs
• Others

Segmentation by Application:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Genentech
• Nanotherapeutics
• Novartis
• Pfizer
• Nymox Pharmaceutical
• Sequoia Sciences
• Phico Therapeutics
• Cantab Biopharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Enterobacteriaceae Infection Drug Market Size (2020-2031)
  2.1.2 Enterobacteriaceae Infection Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Enterobacteriaceae Infection Drug by Country/Region (2020, 2024 & 2031)
2.2 Enterobacteriaceae Infection Drug Segment by Type
  2.2.1 Beta-lactams Drugs
  2.2.2 Carbapenems Drugs
  2.2.3 Fluoroquinolones Drugs
  2.2.4 Others
2.3 Enterobacteriaceae Infection Drug Market Size by Type
  2.3.1 Enterobacteriaceae Infection Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Enterobacteriaceae Infection Drug Market Size Market Share by Type (2020-2025)
2.4 Enterobacteriaceae Infection Drug Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Enterobacteriaceae Infection Drug Market Size by Application
  2.5.1 Enterobacteriaceae Infection Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Enterobacteriaceae Infection Drug Market Size Market Share by Application (2020-2025)

3 ENTEROBACTERIACEAE INFECTION DRUG MARKET SIZE BY PLAYER

3.1 Enterobacteriaceae Infection Drug Market Size Market Share by Player
  3.1.1 Global Enterobacteriaceae Infection Drug Revenue by Player (2020-2025)
  3.1.2 Global Enterobacteriaceae Infection Drug Revenue Market Share by Player (2020-2025)
3.2 Global Enterobacteriaceae Infection Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ENTEROBACTERIACEAE INFECTION DRUG BY REGION

4.1 Enterobacteriaceae Infection Drug Market Size by Region (2020-2025)
4.2 Global Enterobacteriaceae Infection Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Enterobacteriaceae Infection Drug Market Size Growth (2020-2025)
4.4 APAC Enterobacteriaceae Infection Drug Market Size Growth (2020-2025)
4.5 Europe Enterobacteriaceae Infection Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Enterobacteriaceae Infection Drug Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Enterobacteriaceae Infection Drug Market Size by Country (2020-2025)
5.2 Americas Enterobacteriaceae Infection Drug Market Size by Type (2020-2025)
5.3 Americas Enterobacteriaceae Infection Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Enterobacteriaceae Infection Drug Market Size by Region (2020-2025)
6.2 APAC Enterobacteriaceae Infection Drug Market Size by Type (2020-2025)
6.3 APAC Enterobacteriaceae Infection Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Enterobacteriaceae Infection Drug Market Size by Country (2020-2025)
7.2 Europe Enterobacteriaceae Infection Drug Market Size by Type (2020-2025)
7.3 Europe Enterobacteriaceae Infection Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Enterobacteriaceae Infection Drug by Region (2020-2025)
8.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ENTEROBACTERIACEAE INFECTION DRUG MARKET FORECAST

10.1 Global Enterobacteriaceae Infection Drug Forecast by Region (2026-2031)
  10.1.1 Global Enterobacteriaceae Infection Drug Forecast by Region (2026-2031)
  10.1.2 Americas Enterobacteriaceae Infection Drug Forecast
  10.1.3 APAC Enterobacteriaceae Infection Drug Forecast
  10.1.4 Europe Enterobacteriaceae Infection Drug Forecast
  10.1.5 Middle East & Africa Enterobacteriaceae Infection Drug Forecast
10.2 Americas Enterobacteriaceae Infection Drug Forecast by Country (2026-2031)
  10.2.1 United States Market Enterobacteriaceae Infection Drug Forecast
  10.2.2 Canada Market Enterobacteriaceae Infection Drug Forecast
  10.2.3 Mexico Market Enterobacteriaceae Infection Drug Forecast
  10.2.4 Brazil Market Enterobacteriaceae Infection Drug Forecast
10.3 APAC Enterobacteriaceae Infection Drug Forecast by Region (2026-2031)
  10.3.1 China Enterobacteriaceae Infection Drug Market Forecast
  10.3.2 Japan Market Enterobacteriaceae Infection Drug Forecast
  10.3.3 Korea Market Enterobacteriaceae Infection Drug Forecast
  10.3.4 Southeast Asia Market Enterobacteriaceae Infection Drug Forecast
  10.3.5 India Market Enterobacteriaceae Infection Drug Forecast
  10.3.6 Australia Market Enterobacteriaceae Infection Drug Forecast
10.4 Europe Enterobacteriaceae Infection Drug Forecast by Country (2026-2031)
  10.4.1 Germany Market Enterobacteriaceae Infection Drug Forecast
  10.4.2 France Market Enterobacteriaceae Infection Drug Forecast
  10.4.3 UK Market Enterobacteriaceae Infection Drug Forecast
  10.4.4 Italy Market Enterobacteriaceae Infection Drug Forecast
  10.4.5 Russia Market Enterobacteriaceae Infection Drug Forecast
10.5 Middle East & Africa Enterobacteriaceae Infection Drug Forecast by Region (2026-2031)
  10.5.1 Egypt Market Enterobacteriaceae Infection Drug Forecast
  10.5.2 South Africa Market Enterobacteriaceae Infection Drug Forecast
  10.5.3 Israel Market Enterobacteriaceae Infection Drug Forecast
  10.5.4 Turkey Market Enterobacteriaceae Infection Drug Forecast
10.6 Global Enterobacteriaceae Infection Drug Forecast by Type (2026-2031)
10.7 Global Enterobacteriaceae Infection Drug Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Enterobacteriaceae Infection Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Genentech
  11.1.1 Genentech Company Information
  11.1.2 Genentech Enterobacteriaceae Infection Drug Product Offered
  11.1.3 Genentech Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Genentech Main Business Overview
  11.1.5 Genentech Latest Developments
11.2 Nanotherapeutics
  11.2.1 Nanotherapeutics Company Information
  11.2.2 Nanotherapeutics Enterobacteriaceae Infection Drug Product Offered
  11.2.3 Nanotherapeutics Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Nanotherapeutics Main Business Overview
  11.2.5 Nanotherapeutics Latest Developments
11.3 Novartis
  11.3.1 Novartis Company Information
  11.3.2 Novartis Enterobacteriaceae Infection Drug Product Offered
  11.3.3 Novartis Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Novartis Main Business Overview
  11.3.5 Novartis Latest Developments
11.4 Pfizer
  11.4.1 Pfizer Company Information
  11.4.2 Pfizer Enterobacteriaceae Infection Drug Product Offered
  11.4.3 Pfizer Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Pfizer Main Business Overview
  11.4.5 Pfizer Latest Developments
11.5 Nymox Pharmaceutical
  11.5.1 Nymox Pharmaceutical Company Information
  11.5.2 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Product Offered
  11.5.3 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Nymox Pharmaceutical Main Business Overview
  11.5.5 Nymox Pharmaceutical Latest Developments
11.6 Sequoia Sciences
  11.6.1 Sequoia Sciences Company Information
  11.6.2 Sequoia Sciences Enterobacteriaceae Infection Drug Product Offered
  11.6.3 Sequoia Sciences Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Sequoia Sciences Main Business Overview
  11.6.5 Sequoia Sciences Latest Developments
11.7 Phico Therapeutics
  11.7.1 Phico Therapeutics Company Information
  11.7.2 Phico Therapeutics Enterobacteriaceae Infection Drug Product Offered
  11.7.3 Phico Therapeutics Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Phico Therapeutics Main Business Overview
  11.7.5 Phico Therapeutics Latest Developments
11.8 Cantab Biopharmaceuticals
  11.8.1 Cantab Biopharmaceuticals Company Information
  11.8.2 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Product Offered
  11.8.3 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Cantab Biopharmaceuticals Main Business Overview
  11.8.5 Cantab Biopharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Enterobacteriaceae Infection Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Enterobacteriaceae Infection Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Beta-lactams Drugs
Table 4. Major Players of Carbapenems Drugs
Table 5. Major Players of Fluoroquinolones Drugs
Table 6. Major Players of Others
Table 7. Enterobacteriaceae Infection Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Enterobacteriaceae Infection Drug Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Enterobacteriaceae Infection Drug Market Size Market Share by Type (2020-2025)
Table 10. Enterobacteriaceae Infection Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Enterobacteriaceae Infection Drug Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Enterobacteriaceae Infection Drug Market Size Market Share by Application (2020-2025)
Table 13. Global Enterobacteriaceae Infection Drug Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Enterobacteriaceae Infection Drug Revenue Market Share by Player (2020-2025)
Table 15. Enterobacteriaceae Infection Drug Key Players Head office and Products Offered
Table 16. Enterobacteriaceae Infection Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Enterobacteriaceae Infection Drug Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Enterobacteriaceae Infection Drug Market Size Market Share by Region (2020-2025)
Table 21. Global Enterobacteriaceae Infection Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Enterobacteriaceae Infection Drug Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Enterobacteriaceae Infection Drug Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Enterobacteriaceae Infection Drug Market Size Market Share by Country (2020-2025)
Table 25. Americas Enterobacteriaceae Infection Drug Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Enterobacteriaceae Infection Drug Market Size Market Share by Type (2020-2025)
Table 27. Americas Enterobacteriaceae Infection Drug Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Enterobacteriaceae Infection Drug Market Size Market Share by Application (2020-2025)
Table 29. APAC Enterobacteriaceae Infection Drug Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Enterobacteriaceae Infection Drug Market Size Market Share by Region (2020-2025)
Table 31. APAC Enterobacteriaceae Infection Drug Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Enterobacteriaceae Infection Drug Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Enterobacteriaceae Infection Drug Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Country (2020-2025)
Table 35. Europe Enterobacteriaceae Infection Drug Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Enterobacteriaceae Infection Drug Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Enterobacteriaceae Infection Drug
Table 41. Key Market Challenges & Risks of Enterobacteriaceae Infection Drug
Table 42. Key Industry Trends of Enterobacteriaceae Infection Drug
Table 43. Global Enterobacteriaceae Infection Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Enterobacteriaceae Infection Drug Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Enterobacteriaceae Infection Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Enterobacteriaceae Infection Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Genentech Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors
Table 48. Genentech Enterobacteriaceae Infection Drug Product Offered
Table 49. Genentech Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Genentech Main Business
Table 51. Genentech Latest Developments
Table 52. Nanotherapeutics Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors
Table 53. Nanotherapeutics Enterobacteriaceae Infection Drug Product Offered
Table 54. Nanotherapeutics Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Nanotherapeutics Main Business
Table 56. Nanotherapeutics Latest Developments
Table 57. Novartis Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors
Table 58. Novartis Enterobacteriaceae Infection Drug Product Offered
Table 59. Novartis Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Novartis Main Business
Table 61. Novartis Latest Developments
Table 62. Pfizer Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors
Table 63. Pfizer Enterobacteriaceae Infection Drug Product Offered
Table 64. Pfizer Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Pfizer Main Business
Table 66. Pfizer Latest Developments
Table 67. Nymox Pharmaceutical Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors
Table 68. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Product Offered
Table 69. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Nymox Pharmaceutical Main Business
Table 71. Nymox Pharmaceutical Latest Developments
Table 72. Sequoia Sciences Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors
Table 73. Sequoia Sciences Enterobacteriaceae Infection Drug Product Offered
Table 74. Sequoia Sciences Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Sequoia Sciences Main Business
Table 76. Sequoia Sciences Latest Developments
Table 77. Phico Therapeutics Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors
Table 78. Phico Therapeutics Enterobacteriaceae Infection Drug Product Offered
Table 79. Phico Therapeutics Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Phico Therapeutics Main Business
Table 81. Phico Therapeutics Latest Developments
Table 82. Cantab Biopharmaceuticals Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors
Table 83. Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Product Offered
Table 84. Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Cantab Biopharmaceuticals Main Business
Table 86. Cantab Biopharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Enterobacteriaceae Infection Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Enterobacteriaceae Infection Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Enterobacteriaceae Infection Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Enterobacteriaceae Infection Drug Sales Market Share by Country/Region (2024)
Figure 8. Enterobacteriaceae Infection Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Enterobacteriaceae Infection Drug Market Size Market Share by Type in 2024
Figure 10. Enterobacteriaceae Infection Drug in Hospital Pharmacies
Figure 11. Global Enterobacteriaceae Infection Drug Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Enterobacteriaceae Infection Drug in Retail Pharmacies
Figure 13. Global Enterobacteriaceae Infection Drug Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Enterobacteriaceae Infection Drug in Online Pharmacies
Figure 15. Global Enterobacteriaceae Infection Drug Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Enterobacteriaceae Infection Drug Market Size Market Share by Application in 2024
Figure 17. Global Enterobacteriaceae Infection Drug Revenue Market Share by Player in 2024
Figure 18. Global Enterobacteriaceae Infection Drug Market Size Market Share by Region (2020-2025)
Figure 19. Americas Enterobacteriaceae Infection Drug Market Size 2020-2025 ($ millions)
Figure 20. APAC Enterobacteriaceae Infection Drug Market Size 2020-2025 ($ millions)
Figure 21. Europe Enterobacteriaceae Infection Drug Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Enterobacteriaceae Infection Drug Market Size 2020-2025 ($ millions)
Figure 23. Americas Enterobacteriaceae Infection Drug Value Market Share by Country in 2024
Figure 24. United States Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Enterobacteriaceae Infection Drug Market Size Market Share by Region in 2024
Figure 29. APAC Enterobacteriaceae Infection Drug Market Size Market Share by Type (2020-2025)
Figure 30. APAC Enterobacteriaceae Infection Drug Market Size Market Share by Application (2020-2025)
Figure 31. China Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 35. India Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Country in 2024
Figure 38. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Type (2020-2025)
Figure 39. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Application (2020-2025)
Figure 40. Germany Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 41. France Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Enterobacteriaceae Infection Drug Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Enterobacteriaceae Infection Drug Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Enterobacteriaceae Infection Drug Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Enterobacteriaceae Infection Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 54. APAC Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 55. Europe Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 57. United States Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 58. Canada Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 59. Mexico Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 60. Brazil Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 61. China Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 62. Japan Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 63. Korea Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 65. India Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 66. Australia Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 67. Germany Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 68. France Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 69. UK Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 70. Italy Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 71. Russia Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 72. Egypt Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 73. South Africa Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 74. Israel Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 75. Turkey Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)
Figure 76. Global Enterobacteriaceae Infection Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Enterobacteriaceae Infection Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Enterobacteriaceae Infection Drug Market Size 2026-2031 ($ millions)